跳至主要内容
临床试验/NCT06774677
NCT06774677招募中不适用

Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care Management

IRCCS Azienda Ospedaliero-Universitaria di Bologna3 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年12月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
3
主要终点
Extracellular vesicle characterization

研究概览

简要总结

This is a national multi-centre, experimental, cross-sectional, non-profit study.

详细描述

Extracellular vesicles are small particles circulating in plasma and documented as key players of intercellular crosstalk thanks to their cargo of proteins, lipids, and nucleic acids. The driving hypothesis of this study is that in Hairy Cell Leukemia-derived extracellular vesicles contribute to the maintenance of the tumor clone through regulation of selected key cells of the tumor microenvironment including immune cells and stromal cells, likely favoring immune evasion and marrow fibrosis. As a consequence, these circulating particles may be instrumental at identifying a biology-related, disease-specific and extracellular vesicle-based signature associated to outcomes.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Extracellular vesicle characterization

时间窗: 1 years

Verify whether hairy cell leukemia patients at different status (at diagnosis, in complete remission \> 2 years, or relapsed meeting treatment indications) display specific extracellular vesicle-based signatures.

次要结局

  • Functional effects of extracellular vesicles(1 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

Unknown
不适用
Filling Key Research Gaps With Clinical Implications in Mansonellosis and Schistosomiasis: a Network ApproachSchistosoma Mansoni
NCT06311344IRCCS Sacro Cuore Don Calabria di Negrar200
进行中(未招募)
1 期
A mulitnational, multicenter, exploratory pharmacogenomics trial to test the importance of identified genetic markers, and potentially identify new markers of various ovarian responses to GONAL-f® treatment in women undergoing assisted reproduction technology (ART).Ensayo exploratorio farmacogenómico, multinacional y multicéntrico, para examinar la importancia de los marcadores genéticos identificados y, potencialmente, identificar nuevos marcadores de diversas respuestas ováricas al tratamiento con GONAL f® en mujeres sometidas a técnicas de reproducción asistida (ART) - Pharmacogenomics trial of GONAL-f® in ARTFemales undergoing assisted reproductive technology (ART), in vitro fertilisation (IVF) or intra cytoplasmic sperm injection (ICSI)Mujeres sometidas a ténicas de reproducción asistida (ART), fertilización in vitro (IVF) o inyección intracitoplásmica de espermatozoides (ICSI)MedDRA version: 9.1Level: LLTClassification code 10021930Term: Infertility NOS
EUCTR2008-001174-33-ESMerck Serono International, A branch of Laboratoires Serono S.A.
进行中(未招募)
不适用
A mulitnational, multicenter, exploratory pharmacogenomics trial to test the importance of identified genetic markers, and potentially identify new markers of various ovarian responses to GONAL-f® treatment in women undergoing assisted reproduction technology (ART). - Pharmacogenomics trial of GONAL-f® in ARTFemales undergoing assisted reproductive technology (ART), in vitro fertilisation (IVF) or intra cytoplasmic sperm injection (ICSI)MedDRA version: 9.1Level: LLTClassification code 10021930Term: Infertility NOS
EUCTR2008-001174-33-SEMerck Serono International S.A., A branch of Laboratoires Serono S.A.1,500
进行中(未招募)
不适用
A multi-centre, multi-national open study in patients with hepatic cirrhosis to characterise the association between the pharmacokinetics of NRL972 and disease severity - NRL972 in hepatic cirrhosisHepatic cirrhosis.MedDRA version: 9.1Level: PTClassification code 10019641Term: Hepatic cirrhosis
EUCTR2007-002404-18-ATorgine Limited1,200
进行中(未招募)
不适用
A multi-centre, multi-national open study in patients with hepatic cirrhosis to characterise the association between the pharmacokinetics of NRL972 and disease severity - NRL972 in hepatic cirrhosis
EUCTR2007-002404-18-BEorgine Limited1,200